CLINICAL TRIALS PROFILE FOR CHENODIOL
✉ Email this page to a colleague
All Clinical Trials for chenodiol
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00912301 ↗ | Cheno Effect on Transit in Health and IBS-C | Completed | National Center for Research Resources (NCRR) | Phase 2 | 2009-04-01 | The study hypothesis is that the naturally occurring bile acid, chenodeoxycholic acid, induces acceleration of colonic transit in health and in patients with constipation-predominant Irritable Bowel Syndrome (IBS-C). |
NCT00912301 ↗ | Cheno Effect on Transit in Health and IBS-C | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 | 2009-04-01 | The study hypothesis is that the naturally occurring bile acid, chenodeoxycholic acid, induces acceleration of colonic transit in health and in patients with constipation-predominant Irritable Bowel Syndrome (IBS-C). |
NCT00912301 ↗ | Cheno Effect on Transit in Health and IBS-C | Completed | Mayo Clinic | Phase 2 | 2009-04-01 | The study hypothesis is that the naturally occurring bile acid, chenodeoxycholic acid, induces acceleration of colonic transit in health and in patients with constipation-predominant Irritable Bowel Syndrome (IBS-C). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for chenodiol
Condition Name
Clinical Trial Locations for chenodiol
Trials by Country
Clinical Trial Progress for chenodiol
Clinical Trial Phase
Clinical Trial Sponsors for chenodiol
Sponsor Name